Loading…

Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell-Like Properties in Osteosarcoma

Osteosarcoma, a highly aggressive bone cancer, often develops resistance to conventional chemotherapeutics, leading to poor prognosis and survival rates. The malignancy and chemoresistance of osteosarcoma pose significant challenges in its treatment, highlighting the critical need for novel therapeu...

Full description

Saved in:
Bibliographic Details
Published in:Environmental toxicology 2024-11, Vol.39 (11), p.4936-4945
Main Authors: Tsai, Hsiao-Chi, Lien, Ming-Yu, Wang, Shih-Wei, Fong, Yi-Chin, Tang, Chih-Hsin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c1183-40496b6885c7dad14b950b01db61931eca3b9d8dc26e9016b8df36e7685da82c3
container_end_page 4945
container_issue 11
container_start_page 4936
container_title Environmental toxicology
container_volume 39
creator Tsai, Hsiao-Chi
Lien, Ming-Yu
Wang, Shih-Wei
Fong, Yi-Chin
Tang, Chih-Hsin
description Osteosarcoma, a highly aggressive bone cancer, often develops resistance to conventional chemotherapeutics, leading to poor prognosis and survival rates. The malignancy and chemoresistance of osteosarcoma pose significant challenges in its treatment, highlighting the critical need for novel therapeutic approaches. Bruton's tyrosine kinase (BTK) plays a pivotal role in B-cell development and has been linked to various cancers, including breast, lung, and oral cancers, where it contributes to tumor growth and chemoresistance. Despite its established importance in these malignancies, the impact of BTK on osteosarcoma remains unexplored. Our study delves into the expression levels of BTK in osteosarcoma tissues by data from the GEO and TCGA database, revealing a marked increase in BTK expression compared with primary osteoblasts and a potential correlation with primary site progression. Through our investigations, we identified a subset of osteosarcoma cells, named cis-HOS, which exhibited resistance to cisplatin. These cells displayed characteristics of cancer stem cells (CSCs), demonstrated a higher angiogenesis effect, and had an increased migration ability. Notably, an upregulation of BTK was observed in these cisplatin-resistant cells. The application of ibrutinib, a BTK inhibitor, significantly mitigated these aggressive traits. Our study demonstrates that BTK plays a crucial role in conferring chemoresistance in osteosarcoma. The upregulation of BTK in cisplatin-resistant cells was effectively countered by ibrutinib. These findings underscore the potential of targeting BTK as an effective strategy to overcome chemoresistance in osteosarcoma treatment.
doi_str_mv 10.1002/tox.24368
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3072800014</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3116740439</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1183-40496b6885c7dad14b950b01db61931eca3b9d8dc26e9016b8df36e7685da82c3</originalsourceid><addsrcrecordid>eNpdkTtPwzAUhS0E4lEY-APIEgMwpNhx4jgjRLxEpSJR5sixb8HQ2MV2JPrvMeUxMN07fDr6dA5Ch5SMKSH5eXQf47xgXGygXVrmeVblldhc_yQriKA7aC-EV0JIzUu-jXaYqBNP2C5yd_bFdCYa-4wv_RCdPQl4tvIuGAv43lgZAEeHGzfYCF6qiJsX6J2HYEKUVgGWVuPHCD1uYLHIJuYN8IN3S_DRQMDG4mmI4IL0yvVyH23N5SLAwc8doafrq1lzm02mN3fNxSRTlAqWpIuad1yIUlVaalp0dUk6QnXHac0oKMm6Wgutcg41obwTes44VFyUWopcsRE6_c5devc-QIhtb4JKgtKCG0LLSJWLVAgtEnr8D311g7fJrmWU8iq5sDpRZ9-USt0ED_N26U0v_aqlpP1aoU0rtOsVEnv0kzh0Peg_8rd29gmGw4KE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3116740439</pqid></control><display><type>article</type><title>Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell-Like Properties in Osteosarcoma</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Tsai, Hsiao-Chi ; Lien, Ming-Yu ; Wang, Shih-Wei ; Fong, Yi-Chin ; Tang, Chih-Hsin</creator><creatorcontrib>Tsai, Hsiao-Chi ; Lien, Ming-Yu ; Wang, Shih-Wei ; Fong, Yi-Chin ; Tang, Chih-Hsin</creatorcontrib><description>Osteosarcoma, a highly aggressive bone cancer, often develops resistance to conventional chemotherapeutics, leading to poor prognosis and survival rates. The malignancy and chemoresistance of osteosarcoma pose significant challenges in its treatment, highlighting the critical need for novel therapeutic approaches. Bruton's tyrosine kinase (BTK) plays a pivotal role in B-cell development and has been linked to various cancers, including breast, lung, and oral cancers, where it contributes to tumor growth and chemoresistance. Despite its established importance in these malignancies, the impact of BTK on osteosarcoma remains unexplored. Our study delves into the expression levels of BTK in osteosarcoma tissues by data from the GEO and TCGA database, revealing a marked increase in BTK expression compared with primary osteoblasts and a potential correlation with primary site progression. Through our investigations, we identified a subset of osteosarcoma cells, named cis-HOS, which exhibited resistance to cisplatin. These cells displayed characteristics of cancer stem cells (CSCs), demonstrated a higher angiogenesis effect, and had an increased migration ability. Notably, an upregulation of BTK was observed in these cisplatin-resistant cells. The application of ibrutinib, a BTK inhibitor, significantly mitigated these aggressive traits. Our study demonstrates that BTK plays a crucial role in conferring chemoresistance in osteosarcoma. The upregulation of BTK in cisplatin-resistant cells was effectively countered by ibrutinib. These findings underscore the potential of targeting BTK as an effective strategy to overcome chemoresistance in osteosarcoma treatment.</description><identifier>ISSN: 1520-4081</identifier><identifier>ISSN: 1522-7278</identifier><identifier>EISSN: 1522-7278</identifier><identifier>DOI: 10.1002/tox.24368</identifier><identifier>PMID: 38924303</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aggressive behaviour ; Angiogenesis ; Bone cancer ; Bruton's tyrosine kinase ; Cancer ; Cell migration ; Chemoresistance ; Cisplatin ; Kinases ; Malignancy ; Medical prognosis ; Osteosarcoma ; Osteosarcoma cells ; Stem cells ; Tyrosine ; Up-regulation</subject><ispartof>Environmental toxicology, 2024-11, Vol.39 (11), p.4936-4945</ispartof><rights>2024 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1183-40496b6885c7dad14b950b01db61931eca3b9d8dc26e9016b8df36e7685da82c3</cites><orcidid>0000-0002-7113-8352 ; 0000-0001-7522-6352</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38924303$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsai, Hsiao-Chi</creatorcontrib><creatorcontrib>Lien, Ming-Yu</creatorcontrib><creatorcontrib>Wang, Shih-Wei</creatorcontrib><creatorcontrib>Fong, Yi-Chin</creatorcontrib><creatorcontrib>Tang, Chih-Hsin</creatorcontrib><title>Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell-Like Properties in Osteosarcoma</title><title>Environmental toxicology</title><addtitle>Environ Toxicol</addtitle><description>Osteosarcoma, a highly aggressive bone cancer, often develops resistance to conventional chemotherapeutics, leading to poor prognosis and survival rates. The malignancy and chemoresistance of osteosarcoma pose significant challenges in its treatment, highlighting the critical need for novel therapeutic approaches. Bruton's tyrosine kinase (BTK) plays a pivotal role in B-cell development and has been linked to various cancers, including breast, lung, and oral cancers, where it contributes to tumor growth and chemoresistance. Despite its established importance in these malignancies, the impact of BTK on osteosarcoma remains unexplored. Our study delves into the expression levels of BTK in osteosarcoma tissues by data from the GEO and TCGA database, revealing a marked increase in BTK expression compared with primary osteoblasts and a potential correlation with primary site progression. Through our investigations, we identified a subset of osteosarcoma cells, named cis-HOS, which exhibited resistance to cisplatin. These cells displayed characteristics of cancer stem cells (CSCs), demonstrated a higher angiogenesis effect, and had an increased migration ability. Notably, an upregulation of BTK was observed in these cisplatin-resistant cells. The application of ibrutinib, a BTK inhibitor, significantly mitigated these aggressive traits. Our study demonstrates that BTK plays a crucial role in conferring chemoresistance in osteosarcoma. The upregulation of BTK in cisplatin-resistant cells was effectively countered by ibrutinib. These findings underscore the potential of targeting BTK as an effective strategy to overcome chemoresistance in osteosarcoma treatment.</description><subject>Aggressive behaviour</subject><subject>Angiogenesis</subject><subject>Bone cancer</subject><subject>Bruton's tyrosine kinase</subject><subject>Cancer</subject><subject>Cell migration</subject><subject>Chemoresistance</subject><subject>Cisplatin</subject><subject>Kinases</subject><subject>Malignancy</subject><subject>Medical prognosis</subject><subject>Osteosarcoma</subject><subject>Osteosarcoma cells</subject><subject>Stem cells</subject><subject>Tyrosine</subject><subject>Up-regulation</subject><issn>1520-4081</issn><issn>1522-7278</issn><issn>1522-7278</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdkTtPwzAUhS0E4lEY-APIEgMwpNhx4jgjRLxEpSJR5sixb8HQ2MV2JPrvMeUxMN07fDr6dA5Ch5SMKSH5eXQf47xgXGygXVrmeVblldhc_yQriKA7aC-EV0JIzUu-jXaYqBNP2C5yd_bFdCYa-4wv_RCdPQl4tvIuGAv43lgZAEeHGzfYCF6qiJsX6J2HYEKUVgGWVuPHCD1uYLHIJuYN8IN3S_DRQMDG4mmI4IL0yvVyH23N5SLAwc8doafrq1lzm02mN3fNxSRTlAqWpIuad1yIUlVaalp0dUk6QnXHac0oKMm6Wgutcg41obwTes44VFyUWopcsRE6_c5devc-QIhtb4JKgtKCG0LLSJWLVAgtEnr8D311g7fJrmWU8iq5sDpRZ9-USt0ED_N26U0v_aqlpP1aoU0rtOsVEnv0kzh0Peg_8rd29gmGw4KE</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Tsai, Hsiao-Chi</creator><creator>Lien, Ming-Yu</creator><creator>Wang, Shih-Wei</creator><creator>Fong, Yi-Chin</creator><creator>Tang, Chih-Hsin</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QH</scope><scope>7ST</scope><scope>7TN</scope><scope>7U7</scope><scope>7UA</scope><scope>C1K</scope><scope>F1W</scope><scope>H97</scope><scope>K9.</scope><scope>L.G</scope><scope>M7N</scope><scope>SOI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7113-8352</orcidid><orcidid>https://orcid.org/0000-0001-7522-6352</orcidid></search><sort><creationdate>20241101</creationdate><title>Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell-Like Properties in Osteosarcoma</title><author>Tsai, Hsiao-Chi ; Lien, Ming-Yu ; Wang, Shih-Wei ; Fong, Yi-Chin ; Tang, Chih-Hsin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1183-40496b6885c7dad14b950b01db61931eca3b9d8dc26e9016b8df36e7685da82c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aggressive behaviour</topic><topic>Angiogenesis</topic><topic>Bone cancer</topic><topic>Bruton's tyrosine kinase</topic><topic>Cancer</topic><topic>Cell migration</topic><topic>Chemoresistance</topic><topic>Cisplatin</topic><topic>Kinases</topic><topic>Malignancy</topic><topic>Medical prognosis</topic><topic>Osteosarcoma</topic><topic>Osteosarcoma cells</topic><topic>Stem cells</topic><topic>Tyrosine</topic><topic>Up-regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsai, Hsiao-Chi</creatorcontrib><creatorcontrib>Lien, Ming-Yu</creatorcontrib><creatorcontrib>Wang, Shih-Wei</creatorcontrib><creatorcontrib>Fong, Yi-Chin</creatorcontrib><creatorcontrib>Tang, Chih-Hsin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Aqualine</collection><collection>Environment Abstracts</collection><collection>Oceanic Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Water Resources Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Environmental toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsai, Hsiao-Chi</au><au>Lien, Ming-Yu</au><au>Wang, Shih-Wei</au><au>Fong, Yi-Chin</au><au>Tang, Chih-Hsin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell-Like Properties in Osteosarcoma</atitle><jtitle>Environmental toxicology</jtitle><addtitle>Environ Toxicol</addtitle><date>2024-11-01</date><risdate>2024</risdate><volume>39</volume><issue>11</issue><spage>4936</spage><epage>4945</epage><pages>4936-4945</pages><issn>1520-4081</issn><issn>1522-7278</issn><eissn>1522-7278</eissn><abstract>Osteosarcoma, a highly aggressive bone cancer, often develops resistance to conventional chemotherapeutics, leading to poor prognosis and survival rates. The malignancy and chemoresistance of osteosarcoma pose significant challenges in its treatment, highlighting the critical need for novel therapeutic approaches. Bruton's tyrosine kinase (BTK) plays a pivotal role in B-cell development and has been linked to various cancers, including breast, lung, and oral cancers, where it contributes to tumor growth and chemoresistance. Despite its established importance in these malignancies, the impact of BTK on osteosarcoma remains unexplored. Our study delves into the expression levels of BTK in osteosarcoma tissues by data from the GEO and TCGA database, revealing a marked increase in BTK expression compared with primary osteoblasts and a potential correlation with primary site progression. Through our investigations, we identified a subset of osteosarcoma cells, named cis-HOS, which exhibited resistance to cisplatin. These cells displayed characteristics of cancer stem cells (CSCs), demonstrated a higher angiogenesis effect, and had an increased migration ability. Notably, an upregulation of BTK was observed in these cisplatin-resistant cells. The application of ibrutinib, a BTK inhibitor, significantly mitigated these aggressive traits. Our study demonstrates that BTK plays a crucial role in conferring chemoresistance in osteosarcoma. The upregulation of BTK in cisplatin-resistant cells was effectively countered by ibrutinib. These findings underscore the potential of targeting BTK as an effective strategy to overcome chemoresistance in osteosarcoma treatment.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38924303</pmid><doi>10.1002/tox.24368</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-7113-8352</orcidid><orcidid>https://orcid.org/0000-0001-7522-6352</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1520-4081
ispartof Environmental toxicology, 2024-11, Vol.39 (11), p.4936-4945
issn 1520-4081
1522-7278
1522-7278
language eng
recordid cdi_proquest_miscellaneous_3072800014
source Wiley-Blackwell Read & Publish Collection
subjects Aggressive behaviour
Angiogenesis
Bone cancer
Bruton's tyrosine kinase
Cancer
Cell migration
Chemoresistance
Cisplatin
Kinases
Malignancy
Medical prognosis
Osteosarcoma
Osteosarcoma cells
Stem cells
Tyrosine
Up-regulation
title Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell-Like Properties in Osteosarcoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A58%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibiting%20Bruton's%20Tyrosine%20Kinase%20to%20Counteract%20Chemoresistance%20and%20Stem%20Cell-Like%20Properties%20in%20Osteosarcoma&rft.jtitle=Environmental%20toxicology&rft.au=Tsai,%20Hsiao-Chi&rft.date=2024-11-01&rft.volume=39&rft.issue=11&rft.spage=4936&rft.epage=4945&rft.pages=4936-4945&rft.issn=1520-4081&rft.eissn=1522-7278&rft_id=info:doi/10.1002/tox.24368&rft_dat=%3Cproquest_cross%3E3116740439%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1183-40496b6885c7dad14b950b01db61931eca3b9d8dc26e9016b8df36e7685da82c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3116740439&rft_id=info:pmid/38924303&rfr_iscdi=true